Tag Archives: insulin

August, 2018

17 August
Novo Nordisk Acquires Ziylo, Gaining Innovative Technology Platform that Could Accelerate Development of New Diabetes Treatment

BRISTOL and COPENHAGEN, 17 August 2018 - Ziylo and Novo Nordisk A/S today announced that Novo Nordisk has acquired all of the shares of Ziylo, a University of Bristol spin-out company based at Unit DX science incubator in Bristol, UK. Ziylo has been pioneering the use of its platform technology – …
Share

5 April
FDA Approves Bydureon for Use with Basal Insulin in Patients with Type 2 Diabetes with Inadequate Glycemic Control

WILMINGTON, Del.–(BUSINESS WIRE)–AstraZeneca today announced the US Food and Drug Administration (FDA) has approved BYDUREON® (exenatide extended-release) for injectable suspension as an add-on therapy to basal insulin in adults with type 2 diabetes (T2D) with inadequate glycemic control. BYDUREON is approved for adults with T2D whose blood sugar remains uncontrolled on …
Share

22 November
FDA Approves Sanofi’s Soliqua for Treatment of Type 2 Diabetes

Paris, France – November 21, 2016 – Sanofi announced today that the U.S. Food and Drug Administration (FDA) approved once-daily Soliqua (TM) 100/33 (insulin glargine & lixisenatide injection) 100 Units/mL & 33 mcg/mL for the treatment of adults with type 2 diabetes inadequately controlled on basal insulin (less than 60 …
Share

28 September
FDA Approves Medtronic’s Automated Insulin Delivery Device for Type 1 Diabetes

The U.S. Food and Drug Administration today approved Medtronic’s MiniMed 670G hybrid closed looped system, the first FDA-approved device that is intended to automatically monitor glucose (sugar) and provide appropriate basal insulin doses in people 14 years of age and older with type 1 diabetes. The human pancreas naturally supplies …
Share

9 June
First T1D Patient Free from Insulin Therapy After Undergoing New Transplant Technique

MIAMI, June 9, 2016 /PRNewswire-USNewswire/ — A 41-year-old man who was diagnosed with type 1 diabetes at age 11 has become the first patient in Europe to discontinue insulin therapy after receiving a transplant of pancreatic islet cells using an innovative technique developed by the Diabetes Research Institute (DRI) at …
Share